Showing 14,461 - 14,480 results of 102,485 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 14461

    Table_5_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx by Monica Franzese (8983097)

    Published 2022
    “…The cohorts were monitored from the 12th day after the first vaccine dose up to 1 month after the third vaccine dose for a total of eight time points and about 1 year of surveillance (T1 = 12 days after the first dose; T2 = 10 days after the second dose; T3 = 1 month after the second dose; T4 = 3 months after the second dose; T5 = 4 months after the second dose; T6 = 5 months after the second dose; T7 = 7 months after the second dose; T8 = 1 month after the third dose for Group 1; T8* = 9 months after the second dose for Group 2; T9 = 1 month after the third dose for Group 2). …”
  2. 14462
  3. 14463

    Genetic deletion of P2rx7 leads to the alteration of NA and 5-HT levels (A, B), elevation of<sup>3</sup>H-Citalopram binding sites and 5-HT uptake (C) in the mouse hippocampus. by Cecilia Csölle (425362)

    Published 2013
    “…<p>A, B/NA and 5-HT levels were analyzed using HPLC in the hippocampus of naive and LPS (1 mg/kg)-treated P2rx7+/+ and P2rx7−/− mice. …”
  4. 14464
  5. 14465
  6. 14466

    Patient data. by Alexander Neugebauer (2425123)

    Published 2024
    “…Both effects are significantly higher than those found in the control phase (<i>p</i> < 0.001 for required time, <i>p</i> = 0.0165 for number of collisions), with the required time decreasing by 5.9% and number of collisions decreasing by 10.4% after the control phase. …”
  7. 14467
  8. 14468
  9. 14469

    Data Sheet 1_Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine.docx by Xiuwen Wang (267423)

    Published 2025
    “…Objective<p>Both B-cell- and T-cell-mediated immunity are crucial for the effective clearance of viral infection, but little is known about the dynamic characteristics of SARS-CoV-2-specific B-cell and T-cell responses in people living with HIV (PLWH) after a full course of inactivated SARS-CoV-2 vaccination.…”
  10. 14470

    Structural Phase Transition between γ‑Ti<sub>3</sub>O<sub>5</sub> and δ‑Ti<sub>3</sub>O<sub>5</sub> by Breaking of a One-Dimensionally Conducting Pathway by Kenji Tanaka (692662)

    Published 2015
    “…Optical measurement also supports that γ-Ti<sub>3</sub>O<sub>5</sub> is a metallic conductor, while δ-Ti<sub>3</sub>O<sub>5</sub> is a semiconductor with a band gap of 0.07 eV. …”
  11. 14471

    Structural Phase Transition between γ‑Ti<sub>3</sub>O<sub>5</sub> and δ‑Ti<sub>3</sub>O<sub>5</sub> by Breaking of a One-Dimensionally Conducting Pathway by Kenji Tanaka (692662)

    Published 2015
    “…Optical measurement also supports that γ-Ti<sub>3</sub>O<sub>5</sub> is a metallic conductor, while δ-Ti<sub>3</sub>O<sub>5</sub> is a semiconductor with a band gap of 0.07 eV. …”
  12. 14472
  13. 14473
  14. 14474
  15. 14475
  16. 14476
  17. 14477

    Supplementary Figure to Age-Dependent Decrease in TRPM4 Channel Expression but not Trafficking Alters Urinary Bladder Smooth Muscle Contractility by Maxwell et al. by Sarah Maxwell (9510812)

    Published 2020
    “…This is a supplementary figure to Age-Dependent Decrease in TRPM4 Channel Expression but not Trafficking Alters Urinary Bladder Smooth Muscle Contractility by Sarah E. …”
  18. 14478
  19. 14479
  20. 14480

    Baseline characteristics of participants<sup>a</sup>. by Yunmin Han (17729539)

    Published 2024
    “…The weighted prevalence of obesity in all ages significantly increased from 30.8% (29.1%-32.5%) in 2014 to 34.5% (32.9%-36.2%) in 2017 and 37.3% (35.5%-39.1%) in 2021 (<i>p</i> for trend < 0.004). …”